Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. TG Therapeutics Inc’s current trading price is -6.97% away from its 52-week high, while its distance from the 52-week low is 280.34%. The stock’s price range over this period has fluctuated between $6.46 and $26.41. The company, operating within the financial sector, had a trading volume of approximately 3.24 million for the day, which was noticeably lower than the average daily share volume of 3.56 million over the last 3 months.
In terms of market performance, TG Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $26.41 on 09/18/24, and the lowest value was recorded at $6.46 on 10/16/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
TG Therapeutics Inc (TGTX) has experienced a quarterly rise of 11.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.80B and boasts a workforce of 264 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.66, with a change in price of +6.87. Similarly, TG Therapeutics Inc recorded 3,185,914 in trading volume during the last 100 days, posting a change of +38.81%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TGTX stands at 0.63. Similarly, the long-term debt-to-equity ratio is also 0.63.
TGTX Stock Stochastic Average
Today’s raw stochastic average for TG Therapeutics Inc over the last 50 days is 76.29%.This indicates a increase from the raw stochastic average of the past 20 days, which was 64.95%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 38.73% and 25.15%, respectively.
TGTX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 43.85%.However, over the last six months, we can see a weaker performance of 75.50%. Over the last 30 days, the price of TGTX has leaped by -1.29%. And in the last five days, it has surged by 12.50%.
